WKY/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
0.0 |
mmHg |
1.0 |
2.45 |
vascular indwelling catheter method |
0.0 |
0 |
84567 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
-2.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
0.0 |
0 |
84554 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
-1.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
0.0 |
0 |
84569 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
56.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
0.0 |
0 |
84573 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
-3.0 |
mmHg |
1.0 |
2.45 |
vascular indwelling catheter method |
0.0 |
0 |
84545 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
-10.0 |
mmHg |
1.0 |
2.45 |
vascular indwelling catheter method |
0.0 |
0 |
85199 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
53.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
0.0 |
0 |
84571 |
1120 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
artificial cerebrospinal fluid (200 nl) then angiotensin II (90 ng) then candesartan (0.5 ug) (for 0.2 hours) then angiotensin II (90 ng) |
Gabor A and Leenen FH, Brain Res. 2012 Apr 4;1447:28-37. doi: 10.1016/j.brainres.2012.01.060. Epub 2012 Feb 1. |
arterial blood pressure trait |
not specified |
0 days
| 4 |
1.0 |
mmHg |
1.0 |
2.0 |
vascular fluid filled catheter |
0.0 |
0 |
110106 |
2685 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
artificial cerebrospinal fluid (200 nl) then angiotensin II (90 ng) then candesartan (0.05 ug) (for 0.2 hours) then angiotensin II (90 ng) |
Gabor A and Leenen FH, Brain Res. 2012 Apr 4;1447:28-37. doi: 10.1016/j.brainres.2012.01.060. Epub 2012 Feb 1. |
arterial blood pressure trait |
not specified |
0 days
| 3 |
10.0 |
mmHg |
3.0 |
5.2 |
vascular fluid filled catheter |
0.0 |
0 |
110105 |
2685 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
0.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
0.0 |
0 |
84552 |
1120 |